Speaker: Kathy Engler, DVM, DABVP
Topic: "Zennovation in Sedation: Rethinking What is Possible" and "Verdinexor: A Novel Oral Therapy for Canine Lymphoma"
In this educational presentation, we will discuss sedation in dogs. The foundation will be set by reviewing the basic physiology behind commonly used sedatives in dogs. We will discuss the most commonly used sedatives and reversal agents, and introduce the novel sedative Zenalpha (medetomidine and vatinoxan hydrochlorides). Part 2: This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
Dinner Meeting
Simon & Seafort's
420 L Street
Anchorage, AK 99501
907-274-3502
Thursday, February 23, 2023
Check-In: 6:30 PM - 7:00 PM, Alaskan
Presentation: 7:00 PM - 9:00 PM, Alaskan
Register by: Wednesday, February 22, 2023
CE Credits: 2
Contact(s):
Mike Blackburn, Territory Manager
206-321-6400
Mike.Blackburn@dechra.com
Additional Notes: Veterinarians, Technicians, and Practice Managers are invited.